X

RPG Life Sciences Ltd Q2FY24; 30% rise in Profits

RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in the domestic and international market.
The company is a part of RPG group which is a diversified conglomerate with interests in areas of infrastructure, tyres, information technology, pharmaceuticals, energy and plantations. The group is headed by Harsh Goenka.

Financial Results:

RPG Life Sciences Ltd reported Revenues for Q2FY24 of ₹154.00 Crores up from ₹135.00 Crore year on year, a rise of 14.07%.

Total Expenses for Q2FY24 of ₹120.00 Crores up from ₹109.00 Crores year on year, a rise of 10.09%.

Consolidated Net Profit of ₹26.00 Crores up 30.0% from ₹20.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹15.64, up 29.58% from ₹12.07 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post